Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer

Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer

Gabriel Tremblay,1 Christopher Livings,2 Lydia Crowe,2 Venediktos Kapetanakis,2 Andrew Briggs3 1Global Health Economics and Health Technology Assessment, Eisai Inc., Woodcliff Lake, NJ, USA; 2Health Economics, Decision Resources Group, Bicester, Oxfordshire, 3Health Economics and Health Technology A...

Full description

Bibliographic Details
Main Authors: Tremblay G, Livings C, Crowe L, Kapetanakis V, Briggs A
Format: Article
Language:English
Published: Dove Medical Press 2016-06-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
Survival analysis
parametric extrapolation
piecewise models
decision criteria
radioiodine-refractory differentiated thyroid cancer
Online Access:https://www.dovepress.com/determination-of-the-most-appropriate-method-for-extrapolating-overall-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/determination-of-the-most-appropriate-method-for-extrapolating-overall-peer-reviewed-article-CEOR

Similar Items